| Literature DB >> 24118919 |
Matthew K McElwee1, Lindsey A Ho, Jeff W Chou, Marjolein V Smith, Jonathan H Freedman.
Abstract
BACKGROUND: Mercury is a ubiquitous environmental toxicant that exists in multiple chemical forms. A paucity of information exists regarding the differences or similarities by which different mercurials act at the molecular level.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24118919 PMCID: PMC3870996 DOI: 10.1186/1471-2164-14-698
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Effects of Mercurials on Gene Expression in
| sub | 2.0 | 8 | 0.75 | 44 |
| | | (8 ↑, 0 ↓) | | (35 ↑, 9 ↓) |
| low | 7.5 | 74 | 2.0 | 419 |
| | | (68 ↑, 6 ↓) | | (247 ↑, 172 ↓) |
| high | 20 | 403 | 7.5 | 2,791 |
| (316 ↑, 87 ↓) | (1,604 ↑, 1,187 ↓) | |||
Number of genes showing increased (↑) or decreased (↓) steady state mRNA levels.
Most significantly affected mercurial-responsive genes
| Y32G9A.1 | 9.4 | Y32G9A.1 | 77 | Y32G9A.1 | 100 | |||
| Y1H11.2 | 8.5 | F11A5.12 | 24 | F11A5.12 | 98 | |||
| C29F3.1 | 4.2 | Y1H11.2 | 22 | W08E12.2 | | 69 | ||
| F35E12.5 | | 4.0 | H23L24.5 | 22 | F22E5.6 | | 68 | |
| M199.7 | | 4.0 | Y43F8C.1 | 19 | Y53F4B.35 | 67 | ||
| F37B1.8 | -4.2 | T26H2.5 | | -11 | C13A2.4 | | -99 | |
| T08G5.10 | -3.2 | Y32B12A.1 | | -10 | F46B3.17 | -97 | ||
| T26H2.5 | | -3.1 | R05D8.11 | | -7.8 | R05D8.11 | | -93 |
| C05E4.14 | -2.2 | F37B1.8 | -5.9 | F53F4.7 | | -91 | ||
| ZK666.6 | -2.1 | E03H12.3 | -5.4 | T26H2.5 | | -88 | ||
| T08G5.10 | 3.1 | T08G5.10 | 42 | F22E10.4 | 84 | |||
| K01D12.1 | | 2.1 | T08G5.1 | | 29 | C15B12.8 | | 43 |
| M02D8.4 | 2.1 | K11G9.6 | 12 | C45B2.3 | | 25 | ||
| F07C4.10 | | 2.1 | F56A4.2 | | 11 | C17H1.8 | | 21 |
| F15H10.8 | | 2.1 | Y39B6A.1 | | 7.9 | Y70C5C.2 | 21 | |
| | | | T25D10.2 | | -3.8 | K03B8.11 | | -6.0 |
| F49H6.12 | | -3.7 | T15B7.3 | -5.2 | ||||
| F29A7.7 | -3.7 | Y57A10C.1 | | -5.2 | ||||
| F14F8.4 | -2.9 | K05F6.4 | | -5.2 | ||||
| C43G2.2 | -2.8 | F54E7.5 | -5.1 | |||||
Figure 1Venn diagrams of up-regulated and down-regulated genes following low- and high-toxicity HgCland MeHgCl exposures. Venn diagram indicating which genes are commonly and uniquely up- or down-regulated between the low- and high-toxicity HgCl2 and MeHgCl exposures.
Differentially expressed genes following MeHgCl exposures
| B0507.8 | | 2.3 | 2.2 | 2.0 |
| B0554.6 | 2.3 | 3.3 | 8.5 | |
| C15B12.8 | | 2.7 | 14 | 14 |
| C33A12.6 | 2.1 | 3.7 | 3.5 | |
| C34H4.1 | | 2.6 | 6.6 | 13 |
| F07E5.9 | | 2.3 | 4.3 | 4.7 |
| F11A5.12 | 3.8 | 24 | 98 | |
| F11D11.3 | | 2.5 | 6.5 | 33 |
| F15B9.1 | 2.2 | 3.8 | 6.3 | |
| F35E12.5 | | 4.0 | 17 | 32 |
| F37B1.2 | 2.1 | 7.0 | 39 | |
| F53B2.2 | 2.2 | 5.3 | 15 | |
| F56D5.3 | | 2.2 | 5.0 | 7.0 |
| K08F4.7 | 2.4 | 4.4 | 10 | |
| M199.7 | | 4.0 | 4.9 | 4.1 |
| T04H1.9 | 2.4 | 9.6 | 36 | |
| W06H8.2 | | 2.9 | 9.9 | 29 |
| Y1H11.2 | 2.9 | 9.9 | 29 | |
| Y32G9A.1 | 9.4 | 77 | 100 | |
| Y39G10AR.6 | 2.1 | 4.4 | 5.7 | |
| Y43F8C.1 | 3.5 | 19 | 17 | |
| Y45F10B.1 | 2.1 | 5.4 | 17 | |
| ZC239.14 | | 2.5 | 4.4 | 11 |
| ZK697.6 | 2.9 | 4.2 | 2.6 | |
| C05E4.14 | -2.2 | -3.4 | -4.5 | |
| C11E4.7 | | -2.1 | -3.4 | -6.9 |
| C15A11.7 | | -2.1 | -3.9 | -6.7 |
| F11A5.9 | | -2.1 | -2.8 | -8.3 |
| F37B1.8 | -4.2 | -5.9 | -5.4 | |
| T08G5.10 | -3.2 | -3.5 | -3.5 | |
| T26H2.5 | | -3.1 | -11 | -88 |
| ZK666.6 | -2.1 | -3.2 | -3.0 | |
Figure 2Effects of HgCland MeHgCl on metallothionein expression. Wild-type nematodes were exposed to sub-toxicity (2.0 μM for HgCl2; 0.75 μM for MeHgCl ), low-toxicity (7.5 μM for HgCl2; 2.0 μM for MeHgCl), and high-toxicity (20 μM for HgCl2; 7.5 μM for MeHgCl) mercurial concentrations for 24 h. Dark bars, HgCl2; light bars, MeHgCl. Steady-state levels of mtl-1 and mtl-2 were measured using qRT-PCR. Results are displayed as mean log2 ± SEM. Significant differences (p < 0.05) relative to untreated C. elegans are designated with an asterisk.
Figure 3Principal components analysis. Panel A, PCA using all of the genes on the microarray; Panel B, PCA using only significantly, differentially expressed genes. Analyses were performed on three pairs of independent biological replicates. Treatments are designated: 2.0 μM (red), 7.5 μM (green) and 20 μM (dark blue) for HgCl2 and 0.75 μM (purple), 2.0 μM (orange) and 7.5 μM (light blue) for MeHgCl.
Figure 4Hierarchical clustering of microarray experimental replicates. Hierarchical clustering was performed using three independent biological replicates for C. elegans exposed to sub-, low- and high-toxicity HgCl2 and MeHgCl concentrations. Red indicates up-regulation of a gene and blue indicates down-regulation of a gene. The dendrogram indicates the degree to which the expression profiles of individual replicates are similar.
Enriched GO biological processes for differentially expressed genes
| MeHgCl | Sub-toxic | up-regulated | Metabolic process (0.00097) |
| Low-toxic | up-regulated | Lipid glycosylation (4.6E-05) | |
| Response to heat (0.00084) | |||
| Carbohydrate metabolic process (0.0084) | |||
| | Oxidation reduction (0.04) | ||
| | down-regulated | Regulation of transcription (0.032) | |
| High-toxic | up-regulated | Post-translational protein modification (3.4E-67) | |
| Vitelline membrane formation (8.5E-07) | |||
| Lipid glycosylation (1.1E-05) | |||
| Response to heat (0.0022) | |||
| | Enterobactin biosynthetic process (0.044) | ||
| down-regulated | Cell adhesion (9.5E-06) | ||
| Body morphogenesis (1.8E-05) | |||
| Cell-matrix adhesion (4.7E-05) | |||
| Chitin catabolic process (0.00021) | |||
| Regulation of transcription (0.0012) | |||
| Cell wall macromolecule catabolic process (0.025) | |||
| Defense response (0.0035) | |||
| Tail morphogenesis (0.0044) | |||
| Proteolysis (0.0046) | |||
| Cilium morphogenesis (0.012) | |||
| Neuron recognition (0.021) | |||
| Lipid transport (0.021) | |||
| Ubiquitin-dependent catabolic process (0.032) | |||
| Response to oxidative stress (0.035) | |||
| Protein-DNA complex assembly (0.042) | |||
| | Regulation of cell migration (0.046) | ||
| HgCl2 | Low-toxic | up-regulated | Proteolysis (7.4E-06) |
| High-toxic | up-regulated | Lipid glycosylation (2.5E-14) | |
| Transmembrane transport (1.1E-06) | |||
| Carbohydrate metabolic process (2.1E-06) | |||
| Extracellular matrix organization (1.3E-05) | |||
| | Oxidation reduction (0.0084) | ||
| | down-regulated | Body morphogenesis (6.8E-10) | |
| Locomotion (0.018) | |||
| Morphogenesis of an epithelium (0.024) | |||
| Regulation of multicellular organism growth (0.036) |
Figure 5EPIG clustering of co-expressed genes. The average log2 fold-change of genes in the pattern for each experimental replicate and treatment is represented by the individual data points in each box. Red, green, blue, and black data points are untreated, sub-, low-, and high-toxicity exposures, respectively. Data points to the left of the dotted line (closed circles) are HgCl2-responsive genes and those to the right (open circles) are MeHgCl-responsive. The value in the upper left indicates the identification number of the EPIG pattern. The value in the lower left hand indicates the number of genes in the specific pattern. The identity of the genes in each pattern can be found in Additional file 3: Table S5.
Significantly affected GO biological process in each EPIG pattern
| 1 | Oxidative phosphorylation (0.00013) |
| Ion transport (0.00020) | |
| Response to drug (0.00024) | |
| Monovalent inorganic cation transport (0.00031) | |
| | Metal ion transport (0.00032) |
| 2 | Lipid glycosylation (0.0011) |
| Monovalent inorganic cation transport (0.0043) | |
| Metal ion transport (0.0045) | |
| | Transport (0.026) |
| 3 | Lipid storage (0.033) |
| 4 | Defecation (3.4E-05) |
| Oxygen transport (0.00029) | |
| Regulation of pharyngeal pumping (0.00037) | |
| Transmembrane transport (0.0084) | |
| | Neurotransmitter transport (0.021) |
| 5 | Cytokinesis (1.5E-06) |
| | Embryonic development ending in birth or egg hatching (0.045) |
| 6 | Meiosis (0.018) |
| 7 | Embryonic development ending in birth or egg hatching (6.1E-08) |
| Mitotic spindle organization (1.2E-05) | |
| Reproduction (1.8E-05) | |
| Cytokinesis (0.00027) | |
| | Germ cell development (0.0051) |
| 8 | Embryonic development ending in birth or egg hatching (1.4E-28) |
| Nematode larval development (7.1E-14) | |
| Genitalia development (1.0E-12) | |
| Receptor-mediated endocytosis (2.7E-11) | |
| | Protein catabolic process (1.3E-8) |
| 9 | tRNA aminoacylation for protein translation (1.1E-06) |
| Lipid glycosylation (0.0020) | |
| | Positive regulation of growth rate (0.033) |
| 10 | Lipid metabolic process (0.00073) |
| Positive regulation of programmed cell death (0.0019) | |
| Lipid transport (0.0028) | |
| Body morphogenesis (0.0047) | |
| | Cell adhesion (0.0078) |
| 11 | Oviposition (0.014) |
| | Transmembrane transport (0.020) |
| 12 | Embryonic development ending in birth or egg hatching (4.2E-16) |
| Cell division (9.2E-10) | |
| Morphogenesis of an epithelium (1.3E-6) | |
| Mitotic spindle organization (4.1E-6) | |
| Embryonic pattern specification (2.3E-5) |
gene-mercurial interactions
| HgCl2 | F14F9.4 | | 0.00072 | 161 |
| F59D6.2 | | 0.00036 | 129 | |
| B0285.9 | 1.20E-06 | 122 | ||
| C54D10.8 | | 0.0022 | 122 | |
| C18D4.2 | 0.0036 | 107 | ||
| F19C7.5 | | 3.00E-06 | 95 | |
| C16C10.12 | 0.00022 | 94 | ||
| Y39A1B.1 | 0.0017 | 78 | ||
| T09F5.10 | | 0.0061 | 65 | |
| | F37B12.2 | 2.40E-05 | -228 | |
| MeHgCl | F14F9.4 | | 0.0068 | 121 |
| K01D12.1 | | 0.0024 | 54 | |
| F37B12.2 | 2.9E-11 | -354 | ||
| Y45F10B.1 | 0.0016 | -153 | ||
| H23L24.5 | 0.0069 | -148 | ||
| Y113G7B.1 | 0.00057 | -137 | ||
| Y69E1A.8 | | 0.0021 | -104 | |
| T05E7.4 | | 0.00013 | -103 | |
| T22D1.2 | | 0.00079 | -101 | |
| F41H10.8 | 0.010 | -99 |
Effects of mercurial on gene expression in cells
| ABCG2 | Not Detected | - | - | - | -2.0 | -3.0 | -5.3 | - | - | 1.9 | - | - | - | ||||||
| BACE1 | - | - | - | - | - | - | - | - | - | - | -1.9 | -3.1 | - | - | - | - | - | - | |
| BACE2 | - | 1.8 | 2.8 | - | - | - | - | - | - | - | - | - | - | - | -1.7 | - | - | - | |
| CHKA | - | - | 3.8 | - | - | - | - | - | -1.5 | - | -1.4 | -2.3 | - | - | 1.9 | - | - | - | |
| CHKB | - | - | 2.0 | 1.8 | 2.7 | 2.0 | - | - | - | -1.2 | - | -2.0 | - | - | - | - | - | - | |
| ELOVL3 | - | - | 9.8 | - | - | - | - | - | - | - | 11 | 10 | - | - | 8.3 | - | - | 7.0 | |
| ELOVL6 | - | - | 1.8 | - | - | - | - | -2.0 | - | -2.2 | -2.4 | -2.8 | - | - | - | - | - | - | |
| GCLC | - | - | 2.6 | - | - | - | 2.5 | 2.6 | - | 2.8 | 2.1 | - | - | - | - | - | - | - | |
| PARG | - | - | - | - | - | - | - | - | - | - | - | -2.4 | - | - | - | - | - | - | |
The number in each cell indicates the fold-change in expression. Cells containing ”-“ indicate no significant change in gene expression.
Gene-mercurial interactions in human cells
| ABCG2 | HgCl2 | NA | -1% (0.83) | -5% (0.56) |
| | MeHgCl | NA | ||
| BACE1 | HgCl2 | -21% (0.057) | 21% (0.069) | -1% (0.92) |
| | MeHgCl | -11% (0.22) | -3% (0.68) | -28% (0.063) |
| BACE2 | HgCl2 | NA | NA | -2% (0.87) |
| | MeHgCl | NA | NA | -26% (0.30) |
| CHKA | HgCl2 | -26% (0.088) | -3% (0.72) | -20% (0.11) |
| | MeHgCl | |||
| CHKB | HgCl2 | -18% (0.39) | 19% (0.24) | 4% (0.71) |
| | MeHgCl | -10% (0.24) | 1% (0.92) | 5% (0.78) |
| ELOVL3 | HgCl2 | -4% (0.76) | -7% (0.62) | |
| | MeHgCl | -5% (0.53) | 5% (0.35) | |
| ELOVL6 | HgCl2 | -25% (0.35) | 3% (0.91) | |
| | MeHgCl | -28% (0.071) | 3% (0.57) | 20% (0.43) |
| GCLC | HgCl2 | 0% (1.00) | -25% (0.060) | |
| | MeHgCl | -2% (0.45) | 3% (0.82) | |
| PARG | HgCl2 | -15% (0.15) | -4% (0.59) | -22% (0.20) |
| MeHgCl | 6% (0.61) | 1% (0.96) | ||
Significant (at the 0.05 alpha cutoff) positive and negative gene-mercurial interactions are highlighted in bold. Numbers in cells indicate the percent change in viable cells from predicted additive effect of gene knock-down and mercurial exposure. “NA” indicates a condition that was not tested.